MétaCan
Menu
Back to cohort
Record W4323308311 · doi:10.1212/wnl.0000000000207115

Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials

2023· article· en· W4323308311 on OpenAlexafffund
Pâmela C.L. Ferreira, João Pedro Ferrari‐Souza, Cécile Tissot, Bruna Bellaver, Douglas Teixeira Leffa, Firoza Z Lussier, Guilherme Povala, Joseph Therriault, Andréa Lessa Benedet, Nicholas J. Ashton, Ann D. Cohen, Oscar L. López, Dana Tudorascu, William E. Klunk, Jean‐Paul Soucy, Serge Gauthier, Victor L. Villemagne, Henrik Zetterberg, Kaj Blennow, Pedro Rosa‐Neto, Eduardo R. Zimmer, Thomas K. Karikari, Tharick A. Pascoal

Bibliographic record

VenueNeurology · 2023
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsMcGill University
FundersNational Institute on AgingUniversity of California, San DiegoGenentechNational Institutes of HealthOlav Thon StiftelsenUK Dementia Research InstituteJulius ClinicalIXICOH. Lundbeck A/SSiemens HealthineersInstituto Nacional de Ciência e Tecnologia para Excitotoxicidade e NeuroproteçãoEisaiVetenskapsrådetFundação de Amparo à Pesquisa do Estado do Rio Grande do SulConselho Nacional de Desenvolvimento Científico e TecnológicoNational Institute of Biomedical Imaging and BioengineeringCanadian Institutes of Health ResearchProthenaEU Joint Programme – Neurodegenerative Disease ResearchNorthern California Institute for Research and EducationInstituto SerrapilheiraBiogenBioClinicaAlzheimer's AssociationStiftelsen för Gamla TjänarinnorEuropean CommissionHjärnfondenFamiljen Erling-Perssons StiftelseUniversity of Southern CaliforniaU.S. Department of DefenseEli Lilly and CompanyBristol-Myers SquibbF. Hoffmann-La RocheAlzheimer's Drug Discovery FoundationMeso Scale DiagnosticsFoundation for the National Institutes of Health
KeywordsSurrogate endpointClinical trialMedicineInternal medicinePopulationOncologySample size determination

Abstract

fetched live from OpenAlex

OBJECTIVE: To test the utility of longitudinal changes in plasma phosphorylated tau 181 (p-tau181) and neurofilament light chain (NfL) as surrogate markers for clinical trials targeting cognitively unimpaired (CU) populations. METHODS: We estimated the sample size needed to test a 25% drug effect with 80% of power at a 0.05 level on reducing changes in plasma markers in CU participants from Alzheimer's Disease Neuroimaging Initiative database. RESULTS: We included 257 CU individuals (45.5% males; mean age = 73 [6] years; 32% β-amyloid [Aβ] positive). Changes in plasma NfL were associated with age, whereas changes in plasma p-tau181 with progression to amnestic mild cognitive impairment. Clinical trials using p-tau181 and NfL would require 85% and 63% smaller sample sizes, respectively, for a 24-month than a 12-month follow-up. A population enrichment strategy using intermediate levels of Aβ PET (Centiloid 20-40) further reduced the sample size of the 24-month clinical trial using p-tau181 (73%) and NfL (59%) as a surrogate. DISCUSSION: Plasma p-tau181/NfL can potentially be used to monitor large-scale population interventions in CU individuals. The enrollment of CU with intermediate Aβ levels constitutes the alternative with the largest effect size and most cost-effective for trials testing drug effect on changes in plasma p-tau181 and NfL.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.003
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.360
Threshold uncertainty score0.486

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0050.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.084
GPT teacher head0.434
Teacher spread0.350 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations28
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueNeurologySame topicDementia and Cognitive Impairment ResearchFrench-language works237,207